University of Arkansas for Medical Sciences (UAMS) — Little Rock, Arkansas

Public research footprint of University of Arkansas for Medical Sciences (UAMS), compiled from the ClinicalTrials.gov public registry.

1,143

Registered studies

260

Active

110

Recruiting now

685

Completed

168

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Anatomic Stage II Breast Cancer AJCC v8 · Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 · Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Recently updated registry entries

NCT06203600 — Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)
NCT06337318 — Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Arkansas for Medical Sciences (UAMS)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.